R&D Spin offs in the Chemical, Pharmaceutical and Biotech Industry

Core Messages

• R&D spin offs with the appropriate investment strategy can make an important contribution to the flexibilisation of a company's internal R&D and therefore increase productivity.
• R&D spin offs could support the company strategy as well as the R&D strategy of the parent company and increase the innovative ability.
• An important aspect is that total costs are reduced, the flexibility and rapidity of R&D increases, the  commercialisation of the innovations accelerates and the possibility of success rises.
• Besides a clear strategic orientation and focus on content, the quality and conviction of the management team are important to R&D spin offs.
• The relevant assets (laboratories, equipment, patents and other intellectual property) have to be transferred.
• Management and employee participation of equity does not play a dominant role, i.e.  total equity could, in principle, remain with the parent company
• The deciding success factors are the independence and own identity of the spin off.